A B S T R A C T The effect of pentagastrin on lower esophageal sphincter (LES) pressure has been studied in trained, unanesthetized dogs. LES pressure was monitored by an infusion manometric technique. Increasing doses of pentagastrin up to 3 ,g/kg given as an i.v. bolus resulted in increasing rises in LES pressure; larger doses resulted in a lesser effect of shorter duration. Increasing i.v. boluses of methacholine produced greater increases in LES pressure up to a maximum of 5 og/kg; higher doses had similar effects. Atropine (50-100 Ag/ kg) slightly diminished the response of the LES to 2 or 6 og/kg of pentagastrin. In large doses (500-2,000 Ag/ kg), atropine did not diminish the response to pentagastrin and prolonged the response of 6 uxg/kg pentagastrin. Hexamethonium (2 mg/kg i.v.) depressed the peak response to 3 ug/kg pentagastrin slightly but the response to 6 Ag/kg was increased and prolonged. Propranolol (2 mg/kg i.v.) significantly prolonged the effect of 6 *g/kg pentagastrin on the LES. We conclude that the stimulatory effect of pentagastrin is mainly due to a direct action on the LES. A lesser stimulatory effect is due to an action on preganglionic cholinergic neurons. Large doses of pentagastrin have both stimulatory and inhibitory effects. The inhibitory effect is mediated at least in part via preganglionic neurons acting through adrenergic receptors. Ganglionic transmission of the effect may be through muscarinic as well as nicotinic receptors.
'Abbreviation used in this paper: LES, lower esophageal sphincter.
opossums, normal man, and in patients with reflux, achalasia, and Zollinger-Ellison syndrome (1) (2) (3) (4) (5) (6) .
In all of these studies, the dose-response curve showed an increased response to increasing doses up to a peak response; then further increases in dose caused a diminished response. The exact mechanism producing diminished responses to high doses is not understood. The mechanism whereby gastrin produces LES contraction may be relevant to this inhibition at high doses.
In a variety of gastrointestinal muscles, gastrin has been suggested to act by releasing acetylcholine. This suggestion is compatible with the finding that stimulatory effects on antral and jejunal contractions in dogs and in guinea pig ileum are antagonized by atropine and tetrodotoxin (7) (8) (9) (10) . There is some disagreement about whether these effects are blocked by hexamethonium; they were not blocked in studies using in vitro strips (7, 8, 10, 11) but were blocked in studies of the in vitro dog stomach (9) .
Lipshutz et al. (11) found that the effect of gastrin on isolated opossum LES muscle strips was also blocked by atropine and tetrodotoxin, but hexamethonium depressed the response minimally. The current hypothesis is that gastrin acts either on pre-or postganglionic parasympathetic nerves in Auerbach's plexus to release acetylcholine, causing contraction of circular muscle. Pentagastrin is presumed to act on the same receptors and by the same mechanism as gastrin. In this study we have attempted to analyse the mechanisms underlying pentagastrin's action on the LES by selectively stimulating or inhibiting links in the chain of neurons and synapses through which the effects of pentagastrin are thought to be mediated. At the start of an experiment the assembly was placed in the stomach. After a pull-through was done to locate the LES, the four middle recording tubes were positioned in the LES so that the point of respiratory reversal was straddled. The other two catheters then recorded pressure in the distal esophagus and stomach. Two criteria had to be met for the subsequent results to be acceptable: the presence of a steady LES base-line pressure for at least 2 min before the administration of a drug; and no evidence of a tube moving out of the LES during the recording of the stimulated LES pressure. Such movement could be recognized by changes in the direction of the respiratory deflection. These conditions were met in about two-thirds of all attempted experiments. Resting pressure was measured as the mean of end-inspiratory and end-expiratory deflection. The tube recording maximal resting pressure at any time was read as sphincter pressure.
METHODS
Each drug agonist or dose of a drug agonist was given on a separate day, sometimes preceded by an antagonist. Dogs were used in rotation so that each animal was used a similar number of times for each comparison. Pentagastrin and methacholine were used as agonists, atropine, hexamethonium, and propranolol as antagonists; doses were expressed in terms of their salts (methacholine bromide, Sigma Chemical Co., St Response of the LES was quantitated in terms of pressures at various times after drug administration. Peak responses and duration of response (to 150% of the predrug pressure) were determined. In some cases we did not wait for return of LES pressure to predrug levels, since the recovery seemed usually to be exponential and thus slow near the base line; furthermore, there were apparently small random fluctuations in the base line in control and experimental runs. The use of recovery to 100% of control LES pressure would have introduced large experimental errors in the evaluation of duration of action, and recovery to 150%o was adopted as an alternative.
RESULTS
The effect of an i.v. bolus of pentagastrin. Pentagastrin rapidly increased LES resting pressure; the peak occurred after 45-60 s. Thereafter the pressure fell towards base line (Fig. 1 ). Peak responses were 112.2± 4.7, 74.7±9.3, and 76.2±5.1 (mean+SEM) at 3, 4, and 6 ulg/kg. Values after 3 isg/kg were significantly lower (P < 0.05). Furthermore the duration of the increased pressure of the LES was appreciably shorter after high doses of pentagastrin (P < 0.05) (Fig. 2) . In about 20% of the experiments, spontaneous phasic contractions of the LES were observed during the basal period but disappeared after pentagastrin was administered. No phasic contractions were superimposed on the LES pressure increase produced by pentagastrin.
The effect of atropine. Doses of 50 or 100 Ag/kg of atropine intravenously had similar effects and decreased LES pressure from 37 to 19 mm Hg in 60 s (P < 0.01). 500-2,000 ug/kg of atropine i.m. had a similar effect, a decrease in LES pressure from 39 to 20 mm Hg over 20 min. The small doses of atropine were chosen because they completely block the effects of an i.v. bolus of 5 lsg/kg of methacholine. The larger doses were chosen because acetylcholine may be released from nerve varicosities very close to muscle in the LES (Daniel, E. E., unpublished observations), and thus higher doses might be required to inhibit the response to released acetylcholine than to infused methacholine. Pentagastrin TIME (SECONDS) was, however, still capable of elevating LES pressure (e.g. 2 Mg/kg raised the LES pressure from 21.4±1.6 to 53.0±7.8) (P < 0.001); the peak response of the LES to an i.v. bolus of 2 Mg/kg pentagastrin was slightly but significantly diminished (P < 0.005) by low doses (50-100 Mg/kg) of atropine, but a 150% increase in pressure was still observed. After high doses (500-2,000 ug/kg) of atropine, inhibition of pentagastrin's effect on the LES was not observed (Fig. 3A) .
The effect of 6 Mg/kg pentagastrin on the LES was also diminished by 50-100 Mg/kg of atropine. A significant increase in sphincter pressure was however still observed (Fig. 3B) . No significant inhibition of the peak response was observed, however, after high doses of atropine, but the peak response occurred later than in the control. The period of maximum effect of 6 Mg/kg pentagastrin was considerably prolonged by higher doses of atropine, in that there was no significant decrease in pressure from the peak response 2 min after injection; such a decrease occurred in other instances after injection of a high dose of pentagastrin.
The effect of methacholine. An intravenous bolus of methacholine rapidly increased LES pressure; the maximal effect occurred at 45 or 60 s. Unlike the response to pentagastrin, each dose increment up to 5 Mg/kg was followed by an increased response by the LES. Greater doses than 5 Mg/kg did not produce a diminished response (Fig. 4) . The duration of the response was also increased as the dose increased (Fig. 5) A large additional dose of pentagastrin (6 Mg/kg) resulted in no change in peak response to 3 or 12 Mg/kg of methacholine. This dose of pentagastrin had no effect on the falloff of the response to 12 Mg/kg of methacholine. When it was added to 3 Mg/kg of methacholine, the falloff was less abrupt (Fig. 6 ). Thus it was not possible to unmask inhibition of LES pressure by large doses of pentagastrin by administering it at time of peak response to a cholinergic agonist.
The effect of hexamethonium. Hexamethonium depressed the peak response to 3 Mg/kg pentagastrin but had no significant effect on the response to 6 Mg/kg ( Fig. 7A and B) . Hexamethonium also resulted in a slightly slower decline in the response to 6 Mg/kg of pentagastrin. It had no effect on the falloff after 3 Mg/kg of pentagastrin.
The effect of propranolol. Propranolol did not effect resting LES pressure when given alone. Peak response of 6 Mg/kg of pentagastrin was not altered by propranolol. However, there was significant prolongation of the effect (Fig. 8) ; the greater response to pentagastrin after 60 s in propranolol-treated animals was too large to be completely explained by the higher initial pressure in these animals compared to controls. DISCUSSION In these experiments on i.v. bolus of 3 Mg/kg of pentagastrin produced a peak stimulatory effect on the canine LES. With doses greater than 3 Mg/kg, the response was less and falloff more rapid. It is difficult to reconcile these findings with the concept that pentagastrin acts simply on pre-or postganglionic cholinergic neurons to release acetylcholine, as has been suggested by several workers (8, 10, 11) . Such a concept would require the existence of both stimulatory, more sensitive, and inhibitory, less sensitive, cholinergic receptors in the muscle of the LES. Moreover, methacholine, an analogue of acetylcholine, acting on the same receptors on smooth muscle, should have a similar effect on the LES. Instead the dose-response curve to methacholine was a typical hyperbolic one. Higher doses never gave a lesser effect, either in peak response or duration of response.
We conclude that the diminished response to high doses of pentagastrin resulted either from activation of an inhibitory mechanism or blocking of the excitatory mechanism by high doses. FIGuRE 3 A. The effect of 2 Ftg/kg i.v. bolus of pentagastrin on LES pressure after high (500-2,000 pg/kg) and low (50-100 /Lg/kg) doses of atropine (mean±1-SEM). Each point represents the mean±+SEM of at least 11 studies. Pentagastrin significantly increased LES pressure after atropinization (P <0.001). B. The effect of 6 A&g/kg i.v. bolus of pentagastrin on LES pressure after high (500-2,000 ,ug/kg) and low (50-100 jig/kg) doses of atropine (mean+ SEM). A significant inhibition of peak response to pentagastrin was observed after 50-100 ,ug/kg of atropine (P < 0.05). Duration of response after this dose was not affected. 500-2,000 ,ug/kg of atropine delayed the peak response but did not diminish it. Duration of response was considerably prolonged (P < 0.05 at 90 s and < 0.025 at 120 s). TIME (SECONDS) FIGURE 4 The effect of an i.v. bolus of methacholine on LES pressure. Each point is the mean of 21 studies. Methacholine resulted in a maximal effect after 30-60 s. An increasing response to dose increments up to 12 ,ug/kg was observed. L doses lowered resting sphincter pressure by 50%, but did not block the stimulatory effect of low doses of pentagastrin on the LES, nor did it convert the action of higher doses to inhibition. The peak effect of 2 /Ag/kg pentagastrin was slightly reduced after 50-100 ALg/kg of atropine but inhibition was not observed after 500-2,000 Ag/kg of atropine. The peak response to 6 ,.g/kg of pentagastrin was diminished but not blocked by moderate doses of atropine. High doses of atropine did not significantly diminish peak responses to pentagastrin, but significantly prolonged them. These results demonstrate that only a small portion of pentagastrin's excitatory effect on the LES is mediated by an atropine-sensitive cholinergic neuron. A direct effect on the LES musculature appears to be the major mechanism by which pentagastrin increases sphincter pressure. If so, this suggests a different mechanism of action for pentagastrin on LES in dogs than that suggested by Lipshutz et al. (11) in the opossum for gastrin; this might be due to species difference or a difference between experiments in vivo and in vitro. It is probably not due to the use of pentagastrin in this study in vivo in contrast to the use of gastrin in the study of opossum LES in vitro, since both act on similar receptors in all studies to date. A more remote possibility is that pentagastrin's stimulatory action is not directly on smooth muscle but on receptors in nerves that are not atropine-sensitive. Such nerves have been described in the dog (12) . These excitatory effects could not be the "rebound" observed after inhibition of various gut muscles (13, 14) ; there was no prior inhibition. Atropine in large doses did not reduce but augmented slightly the response of the LES to 2 Ag/kg of pentagastrin and decreased the secondary inhibition after 6 ig/kg of pentagastrin. If atropine in these doses acted selectively to block actions of muscarinic agonists, these results and those with methacholine suggest that pentagastrin in permit a conclusion about this paradox; however, we think it probable either that atropine was unable to block inhibitory effects of large doses of pentagastrin in the inhibitory ganglia of the esophagus or that a different adrenergic mechanism of inhibition of the LES was also activated.
METHACHOLINE (3 (gkg)
DiMarino and Cohen (16) reported that noradrenaline release and sympathetic stimulation contributed to increased sphincter pressure in the opossum. Propranolol, a beta-adrenergic blocking agent, prolonged the effect of pentagastrin on the dog LES. An ultimate effect of pentagastrin on beta-adrenergic receptors seemed to be responsible for much of the shortened duration of stimulation with large doses of pentagastrin. Whether this inhibitory effect is due to an effect of pentagastrin on a beta-adrenergic process additional to that in the inhibitory neuron acted on by atropine and hexamethonium remains a matter of conjecture. It is possible that atropine and hexamethonium partly inhibit the excitatory response of the LES by inhibiting activation of sympathetic neurons; if so, the inhibitory effects of large doses of pentagastrin might result from release of enough noradrenaline to overflow to the beta receptors of the LES muscle.
This study indicates that the mechanism of action of pentagastrin on the LES in dogs is much more complicated than previously thought. Low doses have mainly stimulatory actions. The stimulatory effect of pentagastrin appears to be mainly by direct action on the LES, but a lesser stimulatory effect may involve an action on preganglionic cholinergic or adrenergic neurons. Higher doses have both stimulatory and inhibitory effects. The inhibitory process appears to be partly mediated through beta-adrenergic receptors. On the other hand, it seems to be partly at a preganglionic site mediated by acetylcholine release onto autonomic ganglia with both muscarinic and nicotinic ganglionic receptors.
